| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8285936 | Parkinsonism & Related Disorders | 2016 | 5 Pages |
Abstract
We found no difference in the risk of any-type of cancer among PD patients compared to the general population, focusing on 10yrs time-window around the initiation of anti-parkinsonian medications.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Chava Peretz, Ron Gurel, Violet Rozani, Tanya Gurevich, Baruch El-Ad, Judith Tsamir, Nir Giladi,